Thyroid function and risk of sepsis: a population-based prospective cohort study with traditional and genetic epidemiological analyses

• by Marianne S. Thorkildsen, Lise T. Gustad, Bjørn O. Åsvold, Randi M. Mohus, Christina Ellervik, Alexander Teumer, Eirini Marouli, Marco Medici, Jan K. Damås, Helene M. Flatby, Tormod Rogne

• June 29, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

• by Kathryn Wighton

• June 29, 2026

• 3 min

Behavior of serum thyroglobulin in relation to thyroid function under low-thyrotropin conditions in general practice

• by Yosuke Sazumi, Yoshiaki Soejima, Yuki Otsuka, Yasuhiro Nakano, Koichiro Yamamoto, Atsuhito Suyama, Ryosuke Takase, Kohei Oguni, Miho Yasuda, Masanori Furukawa, Fumio Otsuka

• May 15, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min